M. W. J. DAVIE, M.B.; T. M. CHALMERS, M.D.; J. O. HUNTER, M.D.; B. PELC, Ph.D.; E. KODICEK, M.D., Ph.D., F.R.S.
Four patients with advanced chronic renal failure and osteodystrophy were treated with 1-alphahydroxycholecalciferol, a synthetic vitamin D analogue, in a daily oral dose of 1.5 to 2.0 µg, for periods up to 1 year. They showed increased calcium absorption, positive calcium and phosphorus balances, moderate increases in serum calcium levels, marked reductions in serum alkaline phosphatase levels, a decrease in serum immunoreactive parathyroid hormone levels, and radiologic and histologic improvement in bone disease. One patient with proximal myopathy showed improvement in muscular strength. 1-Alphahydroxycholecalciferol appears to be effective therapy for renal osteodystrophy.
DAVIE MWJ, CHALMERS TM, HUNTER JO, PELC B, KODICEK E. 1-Alphahydroxycholecalciferol in Chronic Renal Failure: Studies of the Effect of Oral Doses. Ann Intern Med. ;84:281–285. doi: 10.7326/0003-4819-84-3-281
Download citation file:
Published: Ann Intern Med. 1976;84(3):281-285.
Chronic Kidney Disease, Nephrology.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use